Volume 6: Issue 1

The scientific program of the Pulmonary Hypertension Association is guided by the association’s Scientific Leadership Council. The Council includes the following health care professionals:

David B. Badesch, MD, SLC Chair, University of Colorado Health Sciences Center, Denver, Colorado
Robyn J. Barst, MD, SLC Immediate Past Chair, Columbia Presbyterian Medical Center Babies Hospital, New York, New York
Vallerie V. McLaughlin, MD, SLC Vice-Chair, University of Michigan Health System, Ann Arbor, Michigan
Raymond L. Benza, MD, University of Alabama, Birmingham, Alabama
Todd Bull, MD, University of Colorado Health Sciences Center, Denver, Colorado
Richard N. Channick, MD,

Gérald Simonneau, MD

Download as Powerpoint
Download Figure

When a physician’s curriculum vitae totals 232 articles that he has either authored or coauthored, there is little doubt that he ranks high in the pantheon of pulmonary hypertension researchers. This is just the beginning of Dr Gérald Simonneau’s credentials as a world-class physician and investigator, one of the most widely published authors in the fields of pulmonary hypertension, pulmonary vascular diseases, and pneumology.

Dr Simonneau is Professor of Pneumology and Head, Department of Pulmonary Disease and Intensive Care, Hospital Antoine Beclere-Clamart-University Paris XI. With a deep interest in serving on professional groups

This discussion was moderated by Evelyn M. Horn, MD, Associate Professor of Clinical Medicine and Director, Pulmonary Vascular Disease, Center for Advanced Cardiac Care, Columbia University Medical Center, New York, New York. Panel members included Harrison W. Farber, MD, Director, Pulmonary Hypertension Center, Boston Medical Center, Boston University School of Medicine; Mark Gladwin, MD, Chief, Vascular Medicine Branch, National Heart, Lung, and Blood Institute, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD; Myung H. Park, MD, Director, Pulmonary Vascular Disease Program, University of Maryland School of Medicine.

A New Editor—Building on a Tradition of Excellence

The Scientific Leadership Council of the Pulmonary Hypertension Association

Gérald Simonneau, MD: Pioneer, Mentor, and a Driving Force in Pulmonary Hypertension Research for His Colleagues

Sickle Cell Disease-Associated Pulmonary Hypertension: Overview of Clinical Manifestations and Emerging Therapeutic Options

Hemolysis-Associated Endothelial Dysfunction and Pulmonary Hypertension, an Emerging Cause of Death in the Hemoglobinopathies

Pulmonary Hypertension in Thalassemia: Association with Hemolysis, Arginine Metabolism Dysregulation, and a Hypercoagulable State

Sickle Cell Disease and Pulmonary Hypertension: Addressing the Mixed Pathology and Special Considerations in Diagnosis and Treatment

Conference Abstracts

Guest Editor’s Memo

A Roundtable Discussion Addressing Patient-Centered Care and Quality of Life in Patients With Pulmonary Arterial Hypertension

Editor’s Memo

Pulmonary Hypertension Associated With Parenchymal Lung Disease